T845-1364 Screening compound: 2-(3-ethyl-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)-1-morpholino-1-ethanone

T845-1364 Screening compound: 2-(3-ethyl-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)-1-morpholino-1-ethanone
T845-1364 Screening compound: 2-(3-ethyl-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)-1-morpholino-1-ethanone alternative view

Chemical Structure Depiction of ChemDiv screening compound T845-1364
2-(3-ethyl-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)-1-morpholino-1-ethanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T845-1364

Molecular Formula

C14H22N4O2 (C14 H22 N4 O2)

Compound Name

2-(3-ethyl-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)-1-morpholino-1-ethanone

IUPAC name

n/a

SMILES

CCn1c(CN(CC(N2CCOCC2)=O)CC2)c2nc1

InChI

InChI=1S/C14H22N4O2/c1-2-17-11-15-12-3-4-16(9-13(12)17)10-14(19)18-5-7-20-8-6-18/h11H,2-10H2,1H3

InChI Key

LRXKUBXJBPMNMY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27624351

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

278.35

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

-0.908

Distribution Coefficient, logD

-1.436

Water Solubility, LogSw

-0.61

Polar Surface Area

40.111

Acid Dissociation Constant (pKa)

23.86

Base Dissociation Constant (pKb)

7.78

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

71.40

T845-1364 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T845-1364 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T845-1364?
Check Price and Availability of T845-1364, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T845-1364 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T845-1364
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T845-1364
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T845-1364 available by request